Cargando…
Development of an ELISA assay for the quantification of soluble huntingtin in human blood cells
BACKGROUND: Huntington’s disease (HD) is a monogenic disorder caused by an aberrant expansion of CAG repeats in the huntingtin gene (HTT). Pathogenesis is associated with expression of the mutant (mHTT) protein in the CNS, with its levels most likely related to disease progression and symptom severi...
Autores principales: | Massai, Luisa, Petricca, Lara, Magnoni, Letizia, Rovetini, Luca, Haider, Salman, Andre, Ralph, Tabrizi, Sarah J, Süssmuth, Sigurd D, Landwehrmeyer, Bernhard G, Caricasole, Andrea, Pollio, Giuseppe, Bernocco, Simonetta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221641/ https://www.ncbi.nlm.nih.gov/pubmed/24274906 http://dx.doi.org/10.1186/1471-2091-14-34 |
Ejemplares similares
-
IKBKB reduces huntingtin aggregation by phosphorylating serine 13 via a non-canonical IKK pathway
por: Cariulo, Cristina, et al.
Publicado: (2023) -
Phosphorylation of huntingtin at residue T3 is decreased in Huntington’s disease and modulates mutant huntingtin protein conformation
por: Cariulo, Cristina, et al.
Publicado: (2017) -
Quantification of huntingtin protein species in Huntington’s disease patient leukocytes using optimised electrochemiluminescence immunoassays
por: Hensman Moss, Davina J., et al.
Publicado: (2017) -
Functional Characterization of a Small-Molecule Inhibitor of the DKK1-LRP6 Interaction
por: Iozzi, Sara, et al.
Publicado: (2012) -
Huntingtin and Its Partner Huntingtin-Associated Protein 40: Structural and Functional Considerations in Health and Disease
por: Seefelder, Manuel, et al.
Publicado: (2022)